Log in to save to my catalogue

Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sou...

Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sou...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_426099

Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability

About this item

Full title

Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Neuroendocrinology, 2021-08, Vol.111 (9), p.831-839

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Introduction: Tumor growth rate (TGR), percentage of change in tumor volume/month, has been previously identified as an early radiological biomarker for treatment monitoring in neuroendocrine tumor (NET) patients. We assessed the performance and reproducibility of TGR at 3 months (TGR 3m ) as a predictor factor of progression-free survival (PFS), i...

Alternative Titles

Full title

Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_426099

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_426099

Other Identifiers

ISSN

0028-3835,1423-0194

E-ISSN

1423-0194

DOI

10.1159/000510445

How to access this item